← Back to Search

Behavioral Intervention

Attention Training for COVID-19 Anxiety

N/A
Waitlist Available
Research Sponsored by Palo Alto University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* COVID-19 Anxiety Syndrome Scale \> 7 and/or COVID-19 related loss
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 105 days

Summary

"This trial is testing if training people to focus their attention in a certain way can help reduce anxiety and distress related to COVID-19."

Who is the study for?
This trial is for individuals experiencing significant anxiety related to COVID-19, as indicated by a score greater than 7 on the COVID-19 Anxiety Syndrome Scale or those who have suffered a loss due to the pandemic.
What is being tested?
The study is examining if attention training methods, specifically attention bias modification and attention control training, can alleviate distress and anxiety linked to COVID-19 more effectively than a neutral approach.
What are the potential side effects?
Since this trial involves psychological training interventions rather than medication, side effects are minimal but may include temporary increases in anxiety or discomfort during exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~105 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 105 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
COVID-19 Anxiety Syndrome Scale

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Attention Bias ModificationExperimental Treatment1 Intervention
Group II: Attention Control TrainingActive Control1 Intervention
Group III: Neutral TrainingPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Attention Bias Modification
2022
N/A
~2130

Find a Location

Who is running the clinical trial?

Palo Alto UniversityLead Sponsor
13 Previous Clinical Trials
8,081 Total Patients Enrolled
1 Trials studying Anxiety
63 Patients Enrolled for Anxiety
~3 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top